Skandinaviska Enskilda Banken (SEB)’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $605K | Hold |
|
|||||
|
2025
Q1 | $588K | Hold |
|
|||||
|
2024
Q4 | $875K | Hold |
|
|||||
|
2024
Q3 | $1.26M | Hold |
|
|||||
|
2024
Q2 | $1M | Hold |
|
|||||
|
2024
Q1 | $887K | Sell |
|
|||||
|
2023
Q4 | $7.47M | Hold |
|
|||||
|
2023
Q3 | $7.18M | Hold |
|
|||||
|
2023
Q2 | $10.3M | Buy |
|
|||||
|
2023
Q1 | $7.07M | Sell |
|
|||||
|
2022
Q4 | $8.6M | Buy |
|
|||||
|
2022
Q3 | $8.94M | Buy |
|
|||||
|
2022
Q2 | $6.26M | Buy |
|
|||||
|
2022
Q1 | $4.46M | Sell |
|
|||||
|
2021
Q4 | $6.24M | Buy |
|
|||||
|
2021
Q3 | $6.66M | Buy |
|
|||||
|
2021
Q2 | $2.34M | Buy |
|
|||||
|
2021
Q1 | $1.49M | Hold |
|
|||||
|
2020
Q4 | $2.19M | Buy |
|